Cart
sales@molnova.com
1,2-Dilauroyl-sn-glycero-3-phosphocholine
CAS No. 18194-25-7
1,2-Dilauroyl-sn-glycero-3-phosphocholine( DLPC | 1,2-Dilauroyl-sn-glycero-3-phosphocholine )
Catalog No. M27422 CAS No. 18194-25-7
DLPC is an LRH-1 agonist ligand. DLPC is a phospholipid for biological study.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | In Stock |
|
| 50MG | 58 | In Stock |
|
| 100MG | 87 | In Stock |
|
| 200MG | 140 | In Stock |
|
| 500MG | 249 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1,2-Dilauroyl-sn-glycero-3-phosphocholine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDLPC is an LRH-1 agonist ligand. DLPC is a phospholipid for biological study.
-
DescriptionDLPC is an LRH-1 agonist ligand. DLPC is a phospholipid for biological study.(In Vivo):DLPC treatment induces bile acid biosynthetic enzymes in mouse liver, increases bile acid levels, and lowers hepatic triglycerides and serum glucose. DLPC treatment also decreases hepatic steatosis and improves glucose homeostasis in two mouse models of insulin resistance.
-
In Vitro——
-
In Vivo——
-
SynonymsDLPC | 1,2-Dilauroyl-sn-glycero-3-phosphocholine
-
PathwayOthers
-
TargetOther Targets
-
RecptorSIRT1|UGT1A6
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18194-25-7
-
Formula Weight621.837
-
Molecular FormulaC32H64NO8P
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?Ethanol : 100 mg/mL (160.82 m)
-
SMILESCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jiang LP, et al. The Inhibition of the Components from Shengmai Injection towards UDP-Glucuronosyltransferase. Evid Based Complement Alternat Med. 2014;2014:594354.
molnova catalog
related products
-
ICCB280
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
-
Methyl 2-propylpenta...
Methyl 2-propylpentanoate (2-Propylvaleric acid methyl ester) has potential neuroprotective activity.
-
Pueroside B
Pueroside B may can treat coronary heart disease, it can interact with two or more targets[peroxisome proliferator activated receptor γ (PPAR-γ), angiotensin-converting enzyme (ACE), hydroxymethylglutaryl coenzyme A receptor (HMGR), cyclooxygenase-2 (COX2), and thrombin].
